News

Transcatheter Aortic Valve Implantation (TAVI) Market to Reflect Impressive Growth Rate by 2025

The global Transcatheter Aortic Valve Implantation (TAVI) Market is estimated to reach USD xx million by 2025 and is anticipated to grow at a CAGR of xx% during the forecast period, according to a comprehensive study added by Report Ocean.

The report offers an in-depth analysis of major driving factors, segments, regions & countries and key players in the market. Moreover, the report also outlines the competitive scenarios across different geographies along with key developments which include mergers and acquisitions, new product or services development, R&D activities, thus giving insights to the market players about the major regions gaining traction.

Request a Sample copy of Transcatheter Aortic Valve Implantation (TAVI) market report @ https://www.reportocean.com/industry-verticals/sample-request?report_id=27246

Growth Factors and Restraints

Transcatheter aortic valve implantation (TAVI), also called as transcatheter aortic valve replacement (TAVR), is a minimally invasive surgical procedure, which is performed to treat high-risk patients suffering from aortic stenosis. These high-risk patients refer to the patient population who cannot undergo surgical aortic valve replacement (SAVR) procedure. Older population (above 75 years of age) falls under the high-risk category, as the open-heart procedure is too risky for them. TAVR involves the implantation of transcatheter aortic valves to regenerate the blood circulation ability of the aortic valve. The need for transcatheter aortic valve implantation is on the rise due to the increase in the prevalence of aortic stenosis.

TAVI experiences market growth due to the rise in a geriatric population. Furthermore, advancements in the transcatheter aortic valves and an increase in the adoption rate of TAVI devices drive the market. However, stringent government regulations for approval of transcatheter aortic valves, which are class III medical devices and high cost associated with TAVI hamper the market growth. Conversely, use of TAVI systems for new indications, rise in healthcare expenditure in emerging economies, and an increase in the interest of key players in the TAVI market are projected to provide several growth opportunities for the market throughout the forecast period.

The worldwide Transcatheter Aortic Valve Implantation (TAVI) market research report provides a deep-dive analysis of the present market situation and future market trends. The analysis provided in the report help the manufacturers, companies, service providers, etc. as a major guiding factor for decision making and analyzing the current and future market situations. The report also analyzes the major players operating in the market.

The report segments the TAVI market based on procedure and region. According to the procedure, it is classified into transfemoral implantation, transapical implantation, and transaortic implantation. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, Switzerland, UK, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and LAMEA (Brazil, Israel, South Africa, Saudi Arabia, and Rest of LAMEA).

List of major players operating in the Transcatheter Aortic Valve Implantation (TAVI) market include:

Abbott Laboratories
Boston Scientific Corporation (Symetis SA)
Bracco S.p.A. (HLT, Inc.)
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
JC Medical, Inc.
Medtronic plc
Meril Life Sciences Pvt. Ltd.
NVT AG
Venus Medtech, Inc.

KEY BENEFITS

This report provides an extensive analysis of the current and emerging market trends, and dynamics in the global TAVI market.
An in-depth analysis is conducted by constructing market estimations for the key segments between 2018 and 2025.
This report entails the detailed quantitative analysis of the current trends and future estimations through 2018-2025, which assists to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the growth of the TAVI market is provided.
An in-depth analysis of the current research and clinical developments within the TAVI market is provided.
Key players are profiled, and their strategies are analyzed thoroughly, which interprets the competitive outlook of the market.

Major segments covered in the Transcatheter Aortic Valve Implantation (TAVI) Market report include:

By Procedure

Transfemoral Implantation
Transapical Implantation
Transaortic Implantation

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
Italy
Switzerland
UK
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
LAMEA
Brazil
Israel
South Africa
Saudi Arabia
Rest of LAMEA

For more information and discount on this report, ask your query at: https://www.reportocean.com/industry-verticals/sample-request?report_id=27246

Major highlights of the Table of Contents of the study:

  • Market Overview & Summary
  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
    • Challenges
    • Market Share Analysis
    • PORTERS Analysis
    • PESTEL Analysis
    • Value-chain Analysis

Why purchase this report

  1. The report would provide an in-depth analysis of the current and future market trends
  2. Analysis of both global, regional and country-level markets
  3. Key strategic initiatives are taken by major players operating in the market along with ranking analysis for the key players
  4. Analysis based on historical information along with the current trends to estimate the future of the market
  5. Analysis of the impact of constantly changing global market scenarios on the market

Get in Touch with Us:

Jyoti

Email: sales@reportocean.com

Address: Classic Tower, Rajnagar Extension, Ghaziabad, 201017 – India

Tel: +1 888 212 3539 (US – TOLL FREE)

Website: https://www.reportocean.com/

 

 

/* ]]> */